Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nucleic acid membrane strip and kit for alpha and beta mediterranean anemia gene detection

A technology for thalassemia and gene detection, applied in the direction of DNA/RNA fragments, recombinant DNA technology, etc., can solve the problems of not meeting the simple and fast requirements of clinical diagnosis, high operating requirements, high cost, etc. Optimized space layout, increased birth probability, and convenient operation

Active Publication Date: 2013-09-25
亚能生物技术(深圳)有限公司
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the high operating requirements of these products, cumbersome methods, long time-consuming, and high cost due to independent testing, they still cannot meet the requirements of simple and fast clinical diagnosis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid membrane strip and kit for alpha and beta mediterranean anemia gene detection
  • Nucleic acid membrane strip and kit for alpha and beta mediterranean anemia gene detection
  • Nucleic acid membrane strip and kit for alpha and beta mediterranean anemia gene detection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0070] In order to describe in detail the technical content, structural features, achieved objectives and effects of the present invention, the following will be described in detail in conjunction with the embodiments.

[0071] The invention provides a kit for detecting α and β thalassemia, which mainly consists of two parts, a PCR reagent and a low-density chip, specifically as follows:

[0072] a. The PCR reagent is composed of PCR reaction solution I and PCR reaction solution II, wherein PCR reaction solution I is composed of 3 pairs of deletion α primers, Taq enzyme and other components; PCR reaction solution II is composed of 1 pair of non-deletion α primers and 2 Composition of β primers, Taq enzymes, etc., characterized in that 3 pairs of deletion α primers are 3.7F and 3.7R, 4.2F and 4.2R, SEAF and SEAR; 1 pair of non-deletion α primers are ATF and ATR; 2 pairs of β primers were BF1 and BR1, BF2 and BR2.

[0073] b. The low-density chip consists of a negatively charge...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to diagnostic reagent of mediterranean anemia, in particular to a nucleic acid membrane strip and kit for alpha and beta mediterranean anemia gene detection. The technical scheme is that the nucleic acid membrane strip for alpha and beta mediterranean anemia gene detection comprises a substrate and a specific oligonucleotide probe fixed on the substrate, wherein the specific oligonucleotide probe comprises 6 normal alpha-mediterranean anemia (3 deletion types and 3 mutant types) probes and 17 mutant type beta-mediterranean anemia probes. By means of the nucleic acid membrane strip and the kit, deflection type alpha-mediterranean anemia, non-deflection type alpha-mediterranean anemia and beta-mediterranean anemia can be detected in one step simultaneously. Compared with the existing like technology, 2 unreported beta-mediterranean anemia (-30 and -32) and 1 unreported non-deflection type alpha-mediterranean anemia (alpha WS alpha) are detected simultaneously, occurrence rate of the three mediterranean anemia in China is not low, the risk of leak detection in poor areas can be greatly increased without detection, and severe burden can be brought to families and the society.

Description

technical field [0001] The invention relates to a diagnostic reagent for thalassemia, in particular to a nucleic acid membrane strip and a kit for α and β thalassemia gene detection. Background technique [0002] Thalassemia (Thalassemia, hereinafter referred to as thalassemia) is due to the decrease in the synthesis rate of one or some globin chains in the patient, resulting in the lack of some peptide chains and the relative excess of other peptide chains, resulting in hemolysis caused by an imbalance in the number of peptide chains sexual anemia. There are two main types of thalassemia, α-thalassemia caused by a deficiency of α-globin chain synthesis and β-thalassemia caused by a deficiency of β-globin synthesis. [0003] α-thalassemia (including deletion α-thalassemia and non-deletion α-thalassemia) is one of the most common single-gene genetic diseases in the world. Guangxi, Guangdong, Yunnan, Hainan, Hong Kong, Taiwan and other provinces in southern my country The cit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68C12N15/11
Inventor 刘福平梁少明刘晶晶任维
Owner 亚能生物技术(深圳)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products